Dr. med. M.Sc. Marc Schlaeppi
Head of clinic/institute/center
Zentrum für Integrative Medizin · Dept. I
Sarcoidosis induced by interferon-? in melanoma patients: incidence, clinical manifestations, and management strategies
Heinzerling L, Anliker M, Müller J, Schlaeppi M, von Moos R. Sarcoidosis induced by interferon-? in melanoma patients: incidence, clinical manifestations, and management strategies. J Immunother 2010; 33:834-9.
Oct 1, 2010Sarcoidosis induced by interferon-? in melanoma patients: incidence, clinical manifestations, and management strategies
Oct 1, 2010J Immunother 2010; 33:834-9
Heinzerling Lucie, Anliker Mark, Müller Joachim, Schlaeppi Marc, von Moos Roger
Anthroposophische Medizin in der Onkologie
Schlaeppi M, Büssing A, Müller-Hübenthal B, Heusser P. Anthroposophische Medizin in der Onkologie. Onkologe 2010; 16:901-905.
Aug 1, 2010Anthroposophische Medizin in der Onkologie
Aug 1, 2010Onkologe 2010; 16:901-905
Schlaeppi Marc, Büssing Arndt, Müller-Hübenthal Boris, Heusser Peter
Supportive treatment concepts with fermented mistletoe (Viscum album L.) extracts in cancer patients – summary results from four controlled pharmacoepidemiological cohort studies with a total of 3,376 patients
Schlaeppi M, Bock P, Hanisch J, Karasmann M (2010). Supportive treatment concepts with fermented mistletoe (Viscum album L.) extracts in cancer patients – summary results from four controlled pharmacoepidemiological cohort studies with a total of 3,376 patients. Presented at: ICCMR, Tromso
May 20, 2010Supportive treatment concepts with fermented mistletoe (Viscum album L.) extracts in cancer patients – summary results from four controlled pharmacoepidemiological cohort studies with a total of 3,376 patients
May 20, 2010ICCMR
Schlaeppi Marc, Bock P.R., Hanisch J., Karasmann M.
Feasibility of an Integration of Complementary Medicine into a Palliative Care Unit
Schlaeppi M, Schoop B, Schneider N, Wolf U, Obrist S, Decker M, Endler C, Heusser P, Eychmuller S (2010). Feasibility of an Integration of Complementary Medicine into a Palliative Care Unit. Presented at: ICCMR, Tromso
May 19, 2010Feasibility of an Integration of Complementary Medicine into a Palliative Care Unit
May 19, 2010ICCMR
Schlaeppi Marc, Schoop Barbara, Schneider Nicole, Wolf Ursula, Obrist Stefan, Decker Michael, Endler Christian, Heusser Peter, Eychmuller Steffen
Erstes Symposium für Integrative Onkologie und Forschung in der Schweiz
Wolf U, Heusser P, Cerny T, Schlaeppi M. Erstes Symposium für Integrative Onkologie und Forschung in der Schweiz. Swiss Journal of Integrative Medicine 2010:34-35.
Jan 18, 2010Erstes Symposium für Integrative Onkologie und Forschung in der Schweiz
Jan 18, 2010Swiss Journal of Integrative Medicine 2010:34-35
Wolf Ursula, Heusser Peter, Cerny Thomas, Schlaeppi Marc
Komplementär- und Alternativmedizin bei Krebs
Schlaeppi M. Komplementär- und Alternativmedizin bei Krebs. In: Onkologische Krankenpflege. 5. AuflageHeidelberg: Springer, 2010. ISBN 978-3-642-05126-5. pp. 185-197.
Jan 1, 2010Komplementär- und Alternativmedizin bei Krebs
Jan 1, 2010Springer, ISBN 978-3-642-05126-5
Schlaeppi Marc
Malignes Melanom
Schlaeppi M, Anliker M, Heinzerling L, von Moos R. Malignes Melanom - Inzidenz, Früherkennung und therapeutische Optionen. Facharzt 2010; 2:4-7.
Jan 1, 2010Malignes Melanom
Jan 1, 2010Facharzt 2010; 2:4-7
Schlaeppi Marc, Anliker Mark, Heinzerling Lucie, von Moos Roger
Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial (SAKK 50/07)
von Moos R, Goldinger S, Michielin O, Schuller J, Gillessen Sommer S, Schlaeppi M, Cathomas R, Ochsenbein A, Seifert B, Dummer R (2009). Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial (SAKK 50/07). Presented at: ECCO / ESMO, Berlin
Sep 22, 2009Temozolomide combined with bevacizumab in metastatic melanoma. A multicenter phase II trial (SAKK 50/07)
Sep 22, 2009ECCO / ESMO
von Moos Roger, Goldinger S., Michielin O., Schuller J.C., Gillessen Sommer Silke, Schlaeppi Marc, Cathomas R., Ochsenbein A., Seifert B., Dummer R.
Palliative Care und Komplementärmedizin
Schlaeppi M. Palliative Care und Komplementärmedizin. palliative-ch 2008:4-5.
Jan 1, 2008Palliative Care und Komplementärmedizin
Jan 1, 2008palliative-ch 2008:4-5
Schlaeppi Marc
Malignes Melanom
Schlaeppi M, Anliker M, von Moos R. Malignes Melanom. TMJ 2008; 2:17-19.
Jan 1, 2008Malignes Melanom
Jan 1, 2008TMJ 2008; 2:17-19
Schlaeppi Marc, Anliker Mark, von Moos Roger
Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma
Schlaeppi M, Korte W, von Moos R, Cerny T, Gillessen Sommer S. Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma. Onkologie 2006; 29:531-3.
Nov 1, 2006Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma
Nov 1, 2006Onkologie 2006; 29:531-3
Schlaeppi Marc, Korte Wolfgang, von Moos Roger, Cerny Thomas, Gillessen Sommer Silke
Komplementärmedizin in der Onkologie - eine Einführung
Schlaeppi M, Jungi F, Cerny T. Komplementärmedizin in der Onkologie - eine Einführung. Swiss Medical Forum 2005; 5:686-694.
Jun 1, 2005Komplementärmedizin in der Onkologie - eine Einführung
Jun 1, 2005Swiss Medical Forum 2005; 5:686-694
Schlaeppi Marc, Jungi Felix, Cerny Thomas
Spontaneous breathing in a brain-dead patient?
Schlaeppi M, Fischler M, Schwarz U, Maggiorini M (2001). Spontaneous breathing in a brain-dead patient?. Presented at: European Federation of Internal Medicine EFIM, Edinburgh
May 1, 2001Spontaneous breathing in a brain-dead patient?
May 1, 2001European Federation of Internal Medicine EFIM
Schlaeppi Marc, Fischler M, Schwarz U, Maggiorini M
[Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]
Brändle M, Schlaeppi M, Schmid C. [Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]. Schweiz Med Wochenschr 2000; 130:861.
Jun 3, 2000[Type 2A multiple endocrine neoplasia with cutaneous lichen amyloidosis]
Jun 3, 2000Schweiz Med Wochenschr 2000; 130:861
Brändle Michael, Schlaeppi Marc, Schmid C
[Intractable vomiting, convulsions and megaloblastic anemia: anamnesis, key to diagnosis]
Schlaeppi M, Humair L, de Torrenté A. [Intractable vomiting, convulsions and megaloblastic anemia: anamnesis, key to diagnosis]. Schweiz Med Wochenschr 1999; 129:993-5.
Jul 3, 1999[Intractable vomiting, convulsions and megaloblastic anemia: anamnesis, key to diagnosis]
Jul 3, 1999Schweiz Med Wochenschr 1999; 129:993-5
Schlaeppi Marc, Humair L, de Torrenté A
[Cerebral hemorrhage and "ecstasy"]
Schlaeppi M, Prica A, de Torrenté A. [Cerebral hemorrhage and "ecstasy"]. Praxis (Bern 1994) 1999; 88:568-72.
Mar 25, 1999[Cerebral hemorrhage and "ecstasy"]
Mar 25, 1999Praxis (Bern 1994) 1999; 88:568-72
Schlaeppi Marc, Prica A, de Torrenté A
Role of integrins and evidence for two distinct mechanisms mediating human colorectal carcinoma cell interaction with peritoneal mesothelial cells and extracellular matrix
Schlaeppi M, Rüegg C, Trân-Thang C, Chapuis G, Tevaearai H, Lahm H, Sordat B. Role of integrins and evidence for two distinct mechanisms mediating human colorectal carcinoma cell interaction with peritoneal mesothelial cells and extracellular matrix. Cell Adhes Commun 1997; 4:439-55.
Mar 1, 1997Role of integrins and evidence for two distinct mechanisms mediating human colorectal carcinoma cell interaction with peritoneal mesothelial cells and extracellular matrix
Mar 1, 1997Cell Adhes Commun 1997; 4:439-55
Schlaeppi Marc, Rüegg C, Trân-Thang C, Chapuis G, Tevaearai H, Lahm H, Sordat B
Role of integrines in the interaction between colon derived tumor cell lines and the mesothelium
Schlaeppi M, Rüegg C, Trân-Thang C, Chapuis G, Tevaearai H, Sordat B (1996). Role of integrines in the interaction between colon derived tumor cell lines and the mesothelium. Presented at: Jahreskongress der Schweizerischen Gesellschaft für Chirurgie, Geneva
May 1, 1996Role of integrines in the interaction between colon derived tumor cell lines and the mesothelium
May 1, 1996Jahreskongress der Schweizerischen Gesellschaft für Chirurgie
Schlaeppi Marc, Rüegg C, Trân-Thang C, Chapuis G, Tevaearai H, Sordat B